EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer’s disease

Yunguang Qiu, Yuan Hou, Dhruv Gohel, Yadi Zhou, Jielin Xu, Marina Bykova, Yuxin Yang, James B Leverenz, Andrew A Pieper, Ruth Nussinov, Jessica Z K Caldwell, J Mark Brown und 1 weitere

Cell Reports · 2024-05 · 43 (5) · 114128

DOI: 10.1016/j.celrep.2024.114128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024-05. Verfasst von Yunguang Qiu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Genome Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA; Genomic Medicine Institute, Lerner Research In…. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIAAA NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shifts in the magnitude and nature of gut microbial metabolites have been implicated in Alzheimer's disease (AD), but the host receptors that sense and respond to these metabolites are largely unknown. Here, we develop a systems biology framework that integrates machine learning and multi-omics to identify molecular relationships of gut microbial metabolites with non-olfactory G-protein-coupled receptors (termed the "GPCRome"). We evaluate 1.09 million metabolite-protein pairs connecting 408 human GPCRs and 335 gut microbial metabolites. Using genetics-derived Mendelian randomization and integrative analyses of human brain transcriptomic and proteomic profiles, we identify orphan GPCRs (i.e., GPR84) as potential drug targets in AD and that triacanthine experimentally activates GPR84. We demonstrate that phenethylamine and agmatine significantly reduce tau hyperphosphorylation (p-tau181 and p-tau205) in AD patient induced pluripotent stem cell-derived neurons. This study demonstrates a systems biology framework to uncover the GPCR targets of human gut microbiota in AD and other complex diseases if broadly applied.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGastrointestinal MicrobiomeReceptors, G-Protein-CoupledHumansInduced Pluripotent Stem Cellstau ProteinsProteomicsPhosphorylationBrainNeuronsMultiomics

Stichwörter der Autor:innen

AlphaFold2Alzheimer's diseaseCP: MicrobiologyCP: NeuroscienceG-protein-coupled receptorsMendelian randomizationgut microbial metabolitegut microbiotamachine learningmetabolite-protein interactionmulti-omicsorphan GPCR

Substanzen

Receptors, G-Protein-Coupledtau Proteins

Autor:innen und Institutionen

  • Cleveland Clinic Genome Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA; Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
  • Lou Ruvo Center for Brain Health, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleve…
  • Brain Health Medicines Center, Harrington Discovery Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA; Department of Psychiatry, Case Western Reserve University, Cleveland, OH 44106, USA…
  • Computational Structural Biology Section, Frederick National Laboratory for Cancer Research in the Cancer Innovation Laboratory, National Cancer Institute, Frederick, MD 21702, USA; Department of Human Molecular Genetic…
  • Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH 44195, USA; Lou Ruvo Center for Brain Health, Neurological Institute, Cleveland Clinic, Las V…
  • Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH 44195, USA; Department of Cancer Biology, Lerner Research Institute Cleveland Clinic, Clevela…

Förderung

  • NIDDK NIH HHS
  • NIAAA NIH HHS
  • NIA NIH HHS
  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NCI NIH HHS
  • BLRD VA
  • NINDS NIH HHS

Zitieren

APA

Qiu, Y., Hou, Y., Gohel, D., Zhou, Y., Xu, J., Bykova, M., Yang, Y., Leverenz, J. B., Pieper, A. A., Nussinov, R., Caldwell, J. Z. K., Brown, J. M., & Cheng, F. (2024). Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer’s disease. Cell Reports, 43(5), 114128. https://doi.org/10.1016/j.celrep.2024.114128

Vancouver

Qiu Y, Hou Y, Gohel D, Zhou Y, Xu J, Bykova M, et al. Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer’s disease. Cell Reports. 2024;43(5):114128. doi:10.1016/j.celrep.2024.114128

BibTeX
@article{Qiu2024,
  author = {Qiu, Yunguang and Hou, Yuan and Gohel, Dhruv and Zhou, Yadi and Xu, Jielin and Bykova, Marina and Yang, Yuxin and Leverenz, James B and Pieper, Andrew A and Nussinov, Ruth and Caldwell, Jessica Z K and Brown, J Mark and Cheng, Feixiong},
  title = {Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer’s disease},
  journal = {Cell Reports},
  year = {2024},
  volume = {43},
  number = {5},
  pages = {114128},
  doi = {10.1016/j.celrep.2024.114128}
}
Kostenlos starten →